Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-02

Clinical Trial Update: A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk" [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update indicates Auxora is being studied for acute kidney injury, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Auxora

Snippet

Sponsor: CalciMedica, Inc. | Conditions: Acute Kidney Injury | Phase 2 | Status: ACTIVE_NOT_RECRUITING